Free Trial

Veradigm (NASDAQ:MDRX) Reaches New 52-Week Low - Here's What Happened

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. (NASDAQ:MDRX) shares reached a new 52-week low of $3.00 during trading, closing at $4.65.
  • Wall Street Zen has initiated coverage with a "hold" rating, indicating cautious optimism regarding the company's future performance.
  • Veradigm provides healthcare technology solutions such as electronic health records and analytics services for organizations in various countries.
  • Looking to export and analyze Veradigm data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) hit a new 52-week low during trading on Monday . The company traded as low as $3.00 and last traded at $4.65, with a volume of 1594 shares traded. The stock had previously closed at $4.60.

Analyst Ratings Changes

Separately, Wall Street Zen initiated coverage on Veradigm in a research report on Tuesday, May 20th. They issued a "hold" rating for the company. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $13.00.

Get Our Latest Stock Report on MDRX

Veradigm Stock Performance

The business has a fifty day moving average of $4.69 and a two-hundred day moving average of $4.61.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines